A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia) (DeTACT-ASIA)
A Multi-centre Randomised Controlled Non-inferiority Trial to Compare the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies Versus First-line ACTs + Placebo for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Asia
Sponsor: Mahidol Oxford Tropical Medicine Research Unit
Listed as NCT03939104, this PHASE3 trial focuses on Plasmodium Falciparum Malaria (Uncomplicated) and remains completed. Sponsored by Mahidol Oxford Tropical Medicine Research Unit, it has been updated 12 times since 2021, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Aug 2023 — Apr 2024 [monthly]
Recruiting PHASE3
▶ Show 7 earlier versions
-
Jun 2023 — Aug 2023 [monthly]
Recruiting PHASE3
-
Feb 2022 — Jun 2023 [monthly]
Recruiting PHASE3
-
Sep 2021 — Feb 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2019 — Oct 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mahidol Oxford Tropical Medicine Research Unit
- University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .